Gynofem Healthcare and Pharmaceutical Unlisted Share Price
Gynofem Healthcare and Pharmaceutical unlisted share price is ₹64 per share (indicative, as of 17 Oct 2026). Minimum ticket ₹25,000 (lot of 395 shares), the same for every company. Sector: Consumer. Status: unlisted, no DRHP on record.
All unlisted share prices: dated indicative prices for every company the desk tracks.
Updated 17 Oct 2026, 22:10 IST. Dated dealer references.
BuyUnlistedShares tracks 230 unlisted companies with dated prices; Gynofem Healthcare and Pharmaceutical’s indicative price is ₹64 per share as of 17 Oct 2026, a lot of 395 shares.
Key facts
- Indicative price
- ₹64 per share
- Price as of
- 17 Oct 2026
- Minimum investment
- ₹25,000
- Lot size
- 395 shares
- Sector
- Consumer
- Listing status
- Unlisted
- Settlement
- Demat to demat; terms agreed in writing for each deal
- Last updated
- 17 Oct 2026, 22:10 IST
Indicative and dated. BuyUnlistedShares deals as principal.
Buying at a glance
- Minimum ticket
- ₹25,000
- Price shown
- Indicative, dated 17 Oct 2026
- Delivery
- Shares are credited to your demat account
In plain words
- Lock-in if it lists
- Shares bought before an IPO are generally locked in for six months from the IPO allotment date under SEBI rules. The issue documents set the exact terms.
- Demat
- Yes. ISIN INE0NLL01017: the shares sit in your own demat account and move demat to demat through NSDL or CDSL.
- IPO status
- Unlisted. No DRHP on record.
Facts only, not a rating or a recommendation.
Compare it against the full unlisted share price list: every company the desk quotes, each with a dated indicative price.
Indicative move: 0.0% over 3 months · +6.7% over 1 year.
Key figures
| Market cap | ₹635 Cr |
|---|---|
| Minimum investment | ₹25,000 |
| Lot size | 395 |
| P/E ratio | — |
| ROE | -28.15% |
| Book value | ₹0.64 |
| Face value | ₹1 |
| 52-week high | ₹116 |
| 52-week low | ₹60 |
| ISIN | INE0NLL01017 |
| Dividend yield | — |
Financials (₹ Cr)
| Metric | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | — | 4.37 | 4.94 |
| PAT | — | -0.92 | -2.09 |
| EPS (₹) | — | -0.09 | -0.21 |
About the company
Gynofem Healthcare and Pharmaceuticals Limited is an India-based pharmaceutical company incorporated in 2022 and headquartered in Indore, Madhya Pradesh. The company develops and markets a range of pharmaceutical formulations with a focus on women's health, including products aimed at gynaecology, fertility, maternal nutrition and post-delivery recovery.
Prices shown are indicative and dated. Unlisted shares are illiquid and values can move sharply.
Registered in Indore, Madhya Pradesh.
Registry
- ISIN: INE0NLL01017
- Depository: NSDL & CDSL
- Listed at: Unlisted
- Price as of: 17 Oct 2026
Company facts
| CIN | U24290MP2022PLC063077 |
|---|---|
| Incorporated | 2022 |
| ISIN | INE0NLL01017 |
| Face value | ₹1 |
| Registered office | 75/2/16, S K Compound, Lasudiya Mori, Dewas Naka, Indore, Madhya Pradesh 452010, India |
| Shares outstanding | 9,92,13,89,79,921 |
| Lot size | 395 shares |
| Minimum units | 160 |
| DRHP | Not filed |
Financial statements (₹ Cr)
| Metric | FY24 | FY25 | FY25 vs FY24 |
|---|---|---|---|
| Revenue | 4.37 | 4.94 | +13% |
| Profit after tax | −0.92 | −2.09 | — |
| EPS (₹) | −0.09 | −0.21 | — |
| Net margin | −21% | −42.3% | −21.3 pts |
| Share capital | 9.92 | 9.92 | +0% |
| Reserves & surplus | −1.44 | −3.53 | −145.1% |
| Net worth | 8.48 | 6.39 | −24.6% |
| Fixed assets | 9.29 | 8.95 | −3.7% |
| Trade receivables | 0.68 | 0.98 | — |
| Cash from operations | −0.94 | −0.78 | — |
| Cash from investing | −0.03 | −0.18 | — |
| Cash from financing | 0.95 | 0.94 | — |
| Net cash generated | −0.02 | −0.02 | — |
Key ratios and valuation
| Measure | Value | Basis |
|---|---|---|
| Indicative price | ₹64 | dealer reference, 17 Oct 2026 |
| Market cap | ₹635 Cr | as recorded |
| P/E | — | loss-making, n/a |
| P/B | 100x | price ÷ book value ₹0.64 |
| EPS | ₹−0.21 | per share, FY25 |
| Book value | ₹0.64 | per share, latest books |
| RoE | −28.15% | return on equity, latest FY |
| Debt / equity | 0.37 | latest balance sheet |
| Dividend yield | — | |
| Face value | ₹1 | per share |
| 52-week range | ₹60 – ₹116 | 317 dated quotes, last 12 months |
| Shares outstanding | — | not meaningful |
Shareholding pattern
| Category | Holder | % of equity |
|---|---|---|
| Promoters | Promoters | 92.83% |
| Public | Public | 4.1% |
| Others | Others | 3.07% |
Promoters 92.83% · Public 4.1% · Others 3.07%
Management and promoters
| Name | Designation | Experience |
|---|---|---|
| Nishi Kant Joshi | Director | — |
| Kartikay Joshi | Director | — |
| Anurag Mendhe | Director | — |
Reports and filings
No filings uploaded yet.
Frequently asked questions
What does Gynofem Healthcare and Pharmaceuticals do?
Gynofem Healthcare and Pharmaceuticals Limited is an Indore-based pharmaceutical company incorporated in 2022 that develops and markets formulations focused on women's health, including gynaecology, fertility, maternal nutrition and post-delivery care. It distributes its products through healthcare professionals and a domestic field network covering urban and rural markets, and invests in research and development in gynaecology and obstetrics.
Is Gynofem Healthcare and Pharmaceuticals listed on the stock exchange?
No. Gynofem Healthcare and Pharmaceuticals is currently an unlisted company and its shares do not trade on the NSE or BSE. Its equity changes hands in the private, unlisted market. Any listing or IPO would happen only if and when the company completes the required regulatory process; no listing has taken place as of now.
How can I buy unlisted shares of Gynofem Healthcare and Pharmaceuticals?
Unlisted shares are transacted privately rather than on an exchange, and availability and indicative pricing vary over time. You can contact the desk for current information on availability, the transfer process and documentation.
What are the risks of investing in Gynofem Healthcare unlisted shares?
Unlisted and pre-IPO shares carry higher risk and lower liquidity than listed securities, meaning they can be difficult to sell quickly and at a predictable price. Audited financial disclosures may be limited, valuations can be uncertain, prices can move sharply, and there is no guarantee that the company will ever list. This content is informational and not a recommendation to buy, sell or hold.
What is the Gynofem Healthcare and Pharmaceutical unlisted share price today?
The indicative over-the-counter reference price is ₹64 per share as of 17 Oct 2026. It is a dated dealer reference, refreshed every working day.
Is Gynofem Healthcare and Pharmaceutical listed on a stock exchange?
Not yet. Gynofem Healthcare and Pharmaceutical changes hands in the unlisted market, over the counter and settle into your demat account through NSDL and CDSL.
What is the minimum investment in Gynofem Healthcare and Pharmaceutical?
The minimum ticket is ₹25,000, the same for every company on the site.
What is the ISIN of Gynofem Healthcare and Pharmaceutical?
INE0NLL01017. Holdings are settled in demat form through NSDL and CDSL.
How do I buy Gynofem Healthcare and Pharmaceutical unlisted shares?
Send an enquiry with the quantity you have in mind. The desk replies with a dated quote, the paperwork list and the demat steps, and the shares settle demat to demat into your own account.
Is there a lock-in if Gynofem Healthcare and Pharmaceutical lists?
Pre-IPO shareholders other than promoters are generally locked in for six months from the date of IPO allotment under SEBI ICDR regulation 17. The final offer document sets the exact terms.
Sources
- BuyUnlistedShares indicative price series for Gynofem Healthcare and Pharmaceutical, dated daily · since 12 Sep 2025 (343 dated quotes) · buyunlistedshares.com
How to cite this page: BuyUnlistedShares, “Gynofem Healthcare and Pharmaceutical unlisted share price”, https://buyunlistedshares.com/unlisted-shares/gynofem-healthcare-and-pharmaceutical, as of 17 Oct 2026.
Other Consumer unlisted shares
- A V Thomas & Co. Limited · ₹12,500
- Anglo French Drugs and Industries · ₹1,075
- Anheuser Busch Inbev India (AB InBev) · ₹555
- Apollo Fashion International · ₹44
- Arch Pharmalabs Limited · ₹85
- Auckland Jute Co. Limited · ₹189
Enquire to buy Gynofem Healthcare and Pharmaceutical · Sell a holding
Indicative reference price, dated. BuyUnlistedShares is India's premium unlisted shares desk, run by Gayatri Financial Synergy LLP. In the market since 2002. Data as of 17 Oct 2026.
Before you buy: guides
- How to evaluate an unlisted company before investing
- How Unlisted Share Prices Are Discovered When There Is No Live Order Book
- The risks of buying unlisted and pre-IPO shares in India
- Unlisted Shares Lock-In Period: What Every Investor Must Know (2026)
- Can an NRI invest in unlisted shares in India?
All unlisted shares · IPO calendar · Research & learning · Send an enquiry · Calculators · Jobs · About · Contact · Privacy · Terms · Disclaimer · Grievance redressal
Guides: Start investing · Evaluate a company · How prices are set · Risks · Lock-in periods · After the IPO · Sell ESOPs · NRI investors · Buybacks · Choosing a platform
BuyUnlistedShares (BUS) · Gayatri Financial Synergy LLP (LLPIN ACU-4678) · SCO-39, 1st Floor, HUDA Market, Sector-7, Faridabad, Haryana 121006 · +91 916-916-59-59
